DZP advises OW Proton on the acquisition of an in vitro clinic

DZP's client was OW Proton, a financial services and consulting company controlled by Marek Jutkiewicz, an experienced Polish entrepreneur and investor.

With the support of our experts, OW Proton acquired a majority stake in the companies: Medistica Gynaecology + Fertility – an advanced infertility treatment clinic offering specialised assisted reproduction procedures, including IVF, and Medistica Medicine + Beauty – an aesthetic medicine, dermatology and cosmetology clinic.

The two entities are part of the Medistica Medical Group, a dynamically growing family medical group that was founded in 1995 by Dr Mirosław Szlachcic, a renowned expert in gynaecology, obstetrics and endocrinology.

In addition to the share purchase agreement, the shareholders signed a long-term cooperation agreement.

DZP's advice covered comprehensive legal advice on the transaction, including transaction structuring, a due diligence, support in negotiations, full preparation of documentation and transaction closing.

The project was carried out by a multidisciplinary DZP team led by Przemysław Lach and supervised and supported by Robert Niczyporuk. The team included Jakub Rurka, from the Corporate and M&A Practice, Grzegorz Sprawka and Joanna Kociołek-Ziemba from the Tax Practice, and Zuzanna Zapotoczna and Mateusz Mądry from the Life Sciences Practice. Julia Łysik and Anna Okła-Woźniak advised on real estate aspects, while data protection support was provided to the client by Mateusz Jankowski.